-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
CinCor Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q3 2022.
- CinCor Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$22.2M, a 189% decline year-over-year.
- CinCor Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$82.5M.
- CinCor Pharma, Inc. annual Operating Income (Loss) for 2021 was -$42.5M, a 101% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)